공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 BMAC(Bone Marrow Aspirate Concentrates) 시장 : 성장, 동향, 예측(2020-2025년)

Bone Marrow Aspirate Concentrates Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 921889
페이지 정보 영문
가격
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)


세계의 BMAC(Bone Marrow Aspirate Concentrates) 시장 : 성장, 동향, 예측(2020-2025년) Bone Marrow Aspirate Concentrates Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 BMAC(Bone Marrow Aspirate Concentrates) 시장은 2020-2025년간 5.0%의 CAGR로 성장할 것으로 예측됩니다. BMAC는 골수로부터 채취된 액체로부터 만들어지며, 뼈의 치유에 유익합니다. 정형외과 질환과 스포츠 부상의 유병률 상승, 미용 외과 산업의 성장, 정형외과 수술에서 BMAC 제품의 용도 확대 등이 시장 성장을 촉진하고 있습니다.

세계의 BMAC(Bone Marrow Aspirate Concentrates) 시장을 조사했으며, 시장 개요, 제품·용도·지역별 시장 규모 추정과 예측, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 조사 가정
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 정형외과 질환과 스포츠 부상의 유병률 상승
    • 의료비 증가
  • 시장 성장 저해요인
    • 높은 실패율
  • Porter's Five Forces 분석
    • 구매자의 협상력
    • 공급 기업의 협상력
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제5장 시장 세분화

  • 제품별
    • BMAC(Bone Marrow Aspirate Concentrates) 시스템
    • BMAC(Bone Marrow Aspirate Concentrates) 부속품
  • 용도별
    • 정형외과
    • 창상 치료
    • 말초혈관 질환
    • 혈액암
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 상황

  • 기업 개요
    • Arthrex, Inc
    • Aspire Medical Innovation
    • Cesca Therapeutics Inc
    • EmCyte Corporation
    • Globus Medical, Inc
    • MED & CARE Innovative Solutions
    • MK Alliance Inc.(TotipotentSC)
    • Ranfac Corporation
    • Terumo BCT
    • Zimmer Biomet Holdings, Inc

제7장 시장 기회 및 향후 동향

KSM 20.02.14

The bone marrow aspirate concentrates market is expected to grow with a CAGR of 5.0%, during the forecast period. Bone marrow aspirate concentrate is made from the fluid which is taken from bone marrow. Bone marrow aspirate concentrate represents mononuclear cell concentration, red blood cell, immature myeloid precursors, granulocytes, and platelets which are derived through a minimally invasive procedure that avoids the risks of an open bone graft procedure and this cells can help in the healing of some bone and joint conditions.

Increased prevalence of orthopedic diseases and sports injuries, with high growth of the cosmetic surgery industry and increasing applications of the bone marrow aspirate concentrate (BMAC) products in the cosmetic and orthopedic surgeries, are driving the growth of the bone marrow aspirate concentrate market.

Furthermore, the new technological advancements, favorable government regulations and increasing prevalence of orthopedic diseases are the factors that may further contribute to the bone marrow aspirate concentrate market growth.

Key Market Trends

Orthopedic Surgery Segment is Expected to Hold a Significant Market Share

According to a collaborative survey, conducted by the United Nations and the World Health Organization (WHO), 80-90% people in China are suffering from osteoarthritis, of which more than 55% are aged 60 years or above.

According to the World Health Organization (WHO), around 9.6% of men and 18.0% of women aged over 60 years have symptomatic osteoarthritis in the world. Bone marrow-derived stem cell therapy is considered one of the promising and advanced treatments for osteoarthritis which reduces the injury healing time five to six weeks from four to six months in case of surgery. Hence with the increasing prevalence of osteoarthritis and rising preference for bone marrow-derived stem cell therapy uses are the key factors for the growth of the bone marrow aspirate concentrates market.

North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major share globally in the bone marrow aspirate concentrates market due to rising prevalence of osteoarthritis diseases, rise in technological advancements, and awareness about stem cell therapy in this region.

Osteoarthritis (OA) is the most common joint disorder in the United States which occurs in 10% men and 13% in women aged 60 years or older. According to The Osteoarthritis Research Society International by the year 2030, an estimated 67 million adults aged 18 years and older will have doctor-diagnosed osteoarthritis. Furthermore, the increasing incidence of osteoarthritis diseases and a growing geriatric population in the country is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Bone Marrow Aspirate Concentrates Market is moderately consolidated and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some players are adopting numerous strategies including acquisitions and collaborations to sustain competitive advantage.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Orthopedic Diseases and Sports Injuries
    • 4.2.2 Rise in Healthcare Expenditure
  • 4.3 Market Restraints
    • 4.3.1 High Failure Rate
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Bone Marrow Aspirate Concentrates Systems
    • 5.1.2 Bone Marrow Aspirate Concentrates Accessories
  • 5.2 By Application
    • 5.2.1 Orthopedic Surgery
    • 5.2.2 Wound Healing
    • 5.2.3 Peripheral Vascular Disease
    • 5.2.4 Blood Cancer
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Arthrex, Inc
    • 6.1.2 Aspire Medical Innovation
    • 6.1.3 ThermoGenesis Corp.
    • 6.1.4 EmCyte Corporation
    • 6.1.5 Globus Medical, Inc
    • 6.1.6 MED & CARE Innovative Solutions
    • 6.1.7 Stryker Corporation
    • 6.1.8 Ranfac Corporation
    • 6.1.9 Terumo BCT
    • 6.1.10 Zimmer Biomet Holdings, Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q